Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04611568 · ClinicalTrials.gov registry record · NA
War on Melanoma™ Public Health & Education Campaign
A NA study of Melanoma, sponsored by OHSU Knight Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 75,000
- Enrollment target
- 1
- Study location
NCT04611568 is a NA study of Melanoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 75,000 participants, above the 425-participant average among 266 other Melanoma trials with a reported enrollment target (17547% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04611568, a NA study of Melanoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 75,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die from melanoma and increase the number of melanomas that are identified at an earlier stage.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Educational Intervention
- BEHAVIORAL Health Education
- BEHAVIORAL Media Campaign
Study Locations (1)
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75,000 participants |
| Start Date | 2019-05-14 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04611568
The ClinicalTrials.gov registry entry for NCT04611568 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 75,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 425-participant average among 266 other Melanoma trials with a reported enrollment target (17547% higher). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Melanoma appearing as the primary indexed condition, and to 4 interventions - of which Survey Administration is the first listed.
NCT04611568 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.
Frequently Asked Questions
What is clinical trial NCT04611568 about?
NCT04611568 is a clinical study titled "War on Melanoma™ Public Health & Education Campaign". This trial studies how well a health educational campaign works in increasing early detection of melanoma in Oregon. The health educational campaign may provide information to help people learn about the early signs of melanoma. Increased education in Oregon may decrease the number of people who die...
What is the current status of trial NCT04611568?
This trial is currently recruiting. It is a NA study. The enrollment target is 75,000 participants. The study started on 2019-05-14. Estimated completion is 2025-12-30.
What conditions does trial NCT04611568 study?
This clinical trial studies the following conditions: Melanoma.
What interventions are being tested in trial NCT04611568?
The interventions under investigation include: Survey Administration (OTHER), Educational Intervention (OTHER), Health Education (BEHAVIORAL), Media Campaign (BEHAVIORAL).
Who is sponsoring clinical trial NCT04611568?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04611568 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
RECRUITING · NA
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.